Process: submission:03/18/2022 acceptance:01/22/2023 of enhancer of zeste homolog (ezh2) in

HIGHLIGHTS

  • who: EZH and collaborators from the (UNIVERSITY) have published the Article: Process: Submission:03/18/2022 Acceptance:01/22/2023 of Enhancer of Zeste Homolog (EZH2) in, in the Journal: (JOURNAL)

SUMMARY

    There are physical and functional links between the epigenetic silencing enzymes DNA methyltransferases (DNMTs), histone deacetylases (HDACs) and EZH2 histone methyltransferase (Tan et_al, 2014; Rinke et_al, 2020). The activity of EZH2 is vital for stem_cell development, including hematopoiesis through its cellular proliferation function. EZH2 dysregulation is strongly oncogenic by directing cells toward a cancer stem_cell (CSC) state and by epigenetic silencing . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?